Baxter International Inc. Common Stock (BAX)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Jul 9, 2026Investment Snapshot
- Trading 120% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 2.6% — below-average profitability
- Revenue growing at 6% annually
Baxter International Inc. Common Stock (BAX) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $10.2 billion . Key value metrics: P/E ratio 65.1, P/B ratio 1.68, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Baxter International Inc. Common Stock — Fundamental Analysis Summary
Baxter International Inc. Common Stock (BAX) is currently trading 120% above its Graham Number of $8.92, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 65.1x.
On financial health, BAX shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 2.6% (sector average: -20.6%), and elevated leverage with a debt-to-equity ratio of 1.56.
StockPik's composite Value Score for BAX is 63/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
BAX reports a moderate gross margin of 33.7% (sector average: 39.4%) and a modest operating margin of 4.4%.
BAX shows revenue growing at 6% year-over-year, with earnings declining at 47%.
BAX pays a modest dividend yield of 2.6%.